Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder?

Genet Med. 2017 Dec;19(12). doi: 10.1038/gim.2017.146. Epub 2017 Sep 21.

Sureni V Mullegama¹, Steven D Klein², Dzung C Nguyen², Arang Kim³, Rebecca Signer³, Michelle Fox³, Naghmeh Dorrani³, Andrea Hendershot⁴, Rebecca Mardach⁵, Robert Suddath⁶, Katrina Dipple⁷, Eric Vilain^{2

3}, Derek A Wong³, Joshua L Deignan¹, Stephen D Cederbaum^{2

3

6}, Wayne W Grody^{1

2

3}, Julian A Martinez-Agosto^{2

3

6}

¹ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
² Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
³ Department of Pediatrics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
⁴ California Cryobank, Los Angeles, California, USA.
⁵ Department of Pediatrics and MIND Institute, University of California-Davis, Davis, California USA.
⁶ Department of Child and Adolescent Psychiatry, Resnick Neuropsychiatric Hospital, University of California-Los Angeles, Los Angeles, California, USA.
⁷ Seattle Children's Hospital and Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.

No abstract available

Publication types